Nonmicrocephalic Infarcts with Congenital Zika Syndrome Suspected Only after Neuroimaging Evaluation Compared with Those with Microcephaly at Birth and Postnatally: How Large is the Zika Virus "Iceberg"?
AJNR 38:1427-1434, Aragao, M.F.V.V.,et al, 2017
Zika Virus Associated with Microcephaly
NEJM 374: DOI:10.1056/NEJMoa1600651, Mlakar, J.,et al, 2016
Zika Virus as a Cause of Neurologic Disorders
NEJM 374:1506-1509, Broutet, N.,et al, 2016
Association between Zika Virus and Microcephaly in French Polynesia, 2013-15: a Retrospective Study
Lancet 387:DOI:10.1016/S0140-6736, Cauchemez, S.,et al, 2016
Zika Virus as a Cause of Neurologic Disorders
NEJM 374:1506-1509, Broutet, N.,et al, 2016
Zika Virus
NEJM 374:1552-1563, Petersen, L.R.,et al, 2016
Zika Virus as an Emerging Global Pathogen
JAMA Neurol 73:875-879, Beckham, J.D.,et al, 2016
Congenital Zika Virus Syndrome in Brazil: A Case Series of the first 1501 livebirths with complete investigation
Lancet 388:891-897, Franca, G.V.A.,et al, 2016
Zika Virus: An Emergent Neuropathological Agent
Ann Neurol 80:479-489, White, M.K.,et al, 2016
Arenaviruses: A Neurological Problem at Any Age
Ann Neurol 62:309-311, Gilden,D.H., 2007
Neurotropic Viruses and Cerebral Palsy: Population Based Case-Control Study
BMJ 332:76-79,63, Gibson,C.S.,et al, 2006
White Matter MR Hyperintensities in Adult Patients with Congenital Rubella
AJNR 17:99-103, Barton Lane,E.,et al, 1996
Clinical and NEuroradiol Findings of Congen Hydroceph in Infant Born to Mother with HTLV-I-Assoc Myelopathy
Neurol 42:1406-1408, Tohyama,J.,et al, 1992
Magnetic Resonance Imaging of the Brain in Congenital Rubella Virus and Cytomegalovirus Infections
Neuroradiology 33:239-242, Sugita,K.,et al, 1991
Neurological and Developmental Findings in Children with Cataracts
Am J Dis Child 13:706-710, Pike,M.G.,et al, 1989
Progressive Rubella Panencephalitis
NEJM 292:990-993,1023, Townsend,J.,et al, 1975
Monkeypox-Associated Central Nervous System Disease:A Case Series and Review
Ann Neurol 93:893-905, Money,K.M.,et al, 2023
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
Unpacking the CNS Manifestations of Epstein-Barr Virus:An Imaging Perspective
AJNR 44:1002-1008, Soni,N.,et al, 2023
Three Territory Sign in COVID-19
Acta Neurol Belg doi.10.1007/s13760-021-01842-8, Bhatele, P.,et al, 2022
Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19
Ann Neurol 91:367-379, Novak, P.,et al, 2022
An 8-Year-Old with Acute Onset Ataxia
Neurol 99:305-310, McLaren, J.R.,et al, 2022
What All Physicians Need to Know About the Polio Resurgence in New York State
JAMA online e1-e3, Larkin, H., 2022
Neuroimaging Findings in Parechovirus Encephalitis: A Case Series of Pediatric Patients
Pediatr Neurol 130:41-45, Tierradentro-Garcia, L.O.,et al, 2022
Prognosis and Persistence of Smell and Taste Dysfunction in Patients with covid-19: Meta-Analysis with Parametric Cure Modelling of Recovery Curves
BMJ 378:e0695031, Tan, B.K.J.,et al, 2022
Acute Flaccid Myelitis: Cause, Diagnosis, and Management
Lancet 394:334-397, Murphy, O.C.,et al, 2021
Pediatric Parainfectious Encephalitis Associated with COVID-19
Neurol 96:541-544, Gaughan, M.,et al, 2021
Helping with Public Understand Adverse Events Associated with Covid-19 Vaccinations
JAMA Neurol 78:789-790, Kim, D.D.,et al, 2021
Encephalopathies Associated with Severe COVID-19 Present Neurovascular Unit Alterations without Evidence for Strong Neuroinflammation
Neurol Neuroimmunol Neuroinflamm 8:e1029, Bernard-Valnet, R.,et al, 2021
Progressive Multifocal Leukoencephalopathy in a Patient with Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy
JAMA Neurol 78:736-740, Patel,A.,et al, 2021
Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurol 77:184-191, Luna, G.,et al, 2020
Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19
JAMA Otolaryngology Head Neck Surg doi:10.1001/JAMAOTO.2020.0832, Elieyer, M.,et al, 2020
Neurologic Features in Severe SARS-CoV-2 Infection
NEJM 382:2268-2270, e110, , 2020
Alterations in Smell or Taste in Mildly Symptomatic Outpatients with SARS - CoV-2 Infection
JAMA 323:2089-2090, Spinato, G.,et al, 2020
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
NEJM 382:e38, Zhang, Y.,et al, 2020
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
NEJM 382:e61-e63, Oxley, T.J., et al, 2020
Neurologic Complications of Coronavirus Infections
Neurol 94:809-810, Nath, A., 2020
Preparing a Neurology Department for SARS-CoV-2 (COVID-19)
Neurol 94:886-891, Waldman, G.,et al, 2020
Olfactory Dysfunction in COVID-19
JAMA doi:10.1001/JAMA.2020.8391, Whitcroft, K.L. & Hummel, T., 2020
Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams
Stroke 51:1896-1901, Nguyen, T.N.,et al, 2020
Protected Code Stroke
Stroke 51:1891-1895, Khosravani, H.,et al, 2020
The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection
JAMA Neurol 77:679-680, Pleasure, S.J.,et al, 2020
Early Evidence of Pronounced Brain Involvement in Fatal COVID-19 outcomes
Lancet 395:e109, von Weyhern, C.H.,et al, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke
Stroke 51:e124-e127, Valdes Valderrama, E.,et al, 2020
COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
CT Scanning in Suspected Stroke or Head Trauma: Is It Worth Going the Extra Mile and Including the Chest to Screen for COVID-19 Infection?
AJNR 41:1165-1169, Kwee, R.M.,et al, 2020
Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots
AJNR 41:1177-1178, Jain, R.,et al, 2020
Scoping Review of Prevalence of Neurologic Comorbidities in Patients Hospitalized for COVID-19
Neurol 95:77-84, Herman, C.,et al, 2020
Childhood Multisystem Inflammatory Syndrome
NEJM 383:393-395, Levin, M., 2020